トンドレノーン: 主な代謝が非常に制限されている細菌からの非典型的二次代謝物質
Aaron W Puri1, Emily Mevers2, Timothy R Ramadhar2
1Department of Chemical Engineering, University of Washington , Seattle, Washington 98195, United States.
Journal of the American Chemical Society
|January 24, 2018
まとめ
研究者達は,メタンを酸化するバクテリアによって生成される新しい代謝物であるトゥンドレノンを発見しました. この発見は これらの微生物が 新しい天然化合物や 生物合成経路を発見する 可能性を強調しています
科学分野:
- 微生物学
- 生物化学
- ゲノミクス
背景:
- メタンを酸化するバクテリアは 大気中のメタンの除去に不可欠です
- これらの細菌は複雑で未熟な二次代謝能力を持っています
- ゲノム分析により,新しい代謝産物発見の可能性が明らかになった.
研究 の 目的:
- メチロバクター・トゥンドリパルドゥムの代謝産物であるトゥンドレノンの構造的および遺伝的特徴を明らかにする.
- 生物合成経路とチューンドレノンの生成の調節を調査する.
主な方法:
- メチロバクター・トゥンドリパルドゥムの生物情報解析
- ツンドレノンの構造の解明
- トンドレノンの生物合成遺伝子群との遺伝的関連性
- クオラムセンシング分析
主要な成果:
- 複雑な構造を持つユニークな代謝物であるトゥンドレノンを特定し,特徴づけました.
- ツンドレノンは,コリスマート由来の断片と改変された脂質の尾からなる.
- トンドレノンと生物合成遺伝子群の 遺伝的関連を確立した
- 定数感知がトンドレノンの生成を 制御することを示した.
結論:
- メタンを酸化するバクテリアは,新しい天然製品を生み出す可能性のある多様な二次代謝を備えています.
- ツンドレノンは新しい分子構造で バイオテクノロジーの応用が可能です
- メタンを酸化するバクテリアのさらなる探索は,新しい化合物や経路を発見するために正当化されています.
関連する概念動画
Primary and Secondary Growth in Roots and Shoots
60.7K
Vascular plants, which account for over 90% of the Earth’s vegetation, all undergo primary growth—which lengthens roots and shoots. Many land plants, notably woody plants, also undergo secondary growth—which thickens roots and shoots.
60.7K
Primary and Secondary Reinforcers
1.1K
In psychology, reinforcement is a key concept in behavior modification. B.F. Skinner demonstrated this with his experiments involving rats in what is known as a Skinner box. The rats learned to press a lever to receive food, a primary reinforcer that fulfilled their innate need for nourishment.
Effective reinforcers for humans vary depending on the individual and the context. Primary reinforcers, such as food, water, sleep, shelter, and pleasure, have inherent value and satisfy basic biological...
Effective reinforcers for humans vary depending on the individual and the context. Primary reinforcers, such as food, water, sleep, shelter, and pleasure, have inherent value and satisfy basic biological...
1.1K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234
Secondary Active Transport
138.4K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.4K
Antipsychotic Drugs: Typical and Atypical Agents
933
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
933
What is Metabolism?
132.7K
Overview
132.7K


